Showing results (71-80 of 93) with videos related to
Sort By:
Pageof 10
Journal of Neurosurgery|November 29, 2018
Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarctionTakahiro Namioka, Ai Namioka, Masanori Sasaki, et al.World Neurosurgery|February 22, 2021
Intravenous Infusion of Mesenchymal Stem Cells Enhances Therapeutic Efficacy of Reperfusion Therapy in Cerebral IschemiaRyo Kiyose, Masanori Sasaki, Yuko Kataoka-Sasaki, et al.Journal of Neurotrauma|June 15, 2018
Intravenous Infusion of Mesenchymal Stem Cells Alters Motor Cortex Gene Expression in a Rat Model of Acute Spinal Cord InjuryTsutomu Oshigiri, Toru Sasaki, Masanori Sasaki, et al.Journal of the Neurological Sciences|July 29, 2018
Actin, alpha, cardiac muscle 1 (ACTC1) knockdown inhibits the migration of glioblastoma cells in vitroMasahiko Wanibuchi, Shunya Ohtaki, Satoshi Ookawa, et al.Brain Research|May 27, 2018
Preservation of interhemispheric cortical connections through corpus callosum following intravenous infusion of mesenchymal stem cells in a rat model of cerebral infarctionHiroshi Nagahama, Masahito Nakazaki, Masanori Sasaki, et al.Brain Research|December 10, 2023
Rehabilitation facilitates functional improvement following intravenous infusion of mesenchymal stem cells in the chronic phase of cerebral ischemia in ratsTatsuro Yamashita, Masanori Sasaki, Yuichi Sasaki, et al.Journal of Neurotrauma|May 25, 2022
Enhanced Network in Corticospinal Tracts after Infused Mesenchymal Stem Cells in Spinal Cord InjuryRyosuke Hirota, Masanori Sasaki, Yuko Kataoka-Sasaki, et al.Journal of Neurosurgical Sciences|January 13, 2017
Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomasMasahiko Wanibuchi, Yuko Kataoka-Sasaki, Masanori Sasaki, et al.Brain Communications|January 9, 2026
Mesenchymal stem cells reverse disease-specific abnormalities in nociceptive regions of the brainRyunosuke Fukushi, Masanori Sasaki, Hisashi Obara, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion modelKazuhiko Kurozumi, Kiminori Nakamura, Takashi Tamiya, et al.Pageof 10